Inventor
Kirill A. Lukin
Inventor
Vernon Hills, IL, US
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07CAcyclic or carbocyclic compounds17%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture10%
C07BGeneral methods of organic chemistry6%
Y02PClimate change mitigation technologies in the production or processing of goods6%
A61KPreparations for medical, dental or toiletry purposes4%
C07HSugars2%
C07KPeptides2%
PatentTitleYear
10,442,792Synthetic route to anti-viral agents201910,421,712Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereof201910,077,256Synthetic route to anti-viral agents20189,809,576'Synthetic route to anti-viral agents'20179,809,534'Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereof'20179,346,785'Process for making HCV protease inhibitors'20168,519,186'Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype 1 (VR1) receptors'20138,487,116'Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor'20138,273,767'Bicyclic-substituted amines as histamine-3 receptor ligands'20128,232,411'Methods for making central nervous system agents that are TRPV1 antagonists'20128,071,762'Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor'20117,956,195'Process for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane-carboxylates'20117,847,104'Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype1 (VR1) receptors'20107,375,126'Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor'20087,189,849'Synthesis of acyclic nucleoside derivatives'20077,153,889'Bicyclic-substituted amines as histamine-3 receptor ligands'20067,098,222'Bicyclic-substituted amines having cyclic-substituted monocyclic substituents'20066,455,680'Methods utilizing aryl thioimines in synthesis of erythromycin derivatives'20026,184,376'Synthesis of acyclic nucleoside derivatives'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2012Based in Mundelein, IL, US· patent location history
2002–2012Patents assigned to ABBOTT LAB (9)· patent assignee history
2008–2019Based in Vernon Hills, IL, US· patent location history
2011–2013Patents assigned to LUKIN KIRILL A (5)· patent assignee history
2011–2013Patents assigned to HSU MARGARET CHI-PING (3)· patent assignee history
2011–2013Patents assigned to BAYBURT EROL K (2)· patent assignee history
2013–2019Patents assigned to ABBVIE INC (8)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBOTT LAB | 9 | 2002–2012 |
| ABBVIE INC | 8 | 2013–2019 |
| LUKIN KIRILL Aself | 5 | 2011–2013 |
| HSU MARGARET CHI-PING | 3 | 2011–2013 |
| BAYBURT EROL K | 2 | 2011–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Vernon Hills, Illinois, US | 13 | 2008–2019 |
| Mundelein, Illinois, US | 6 | 2001–2012 |